EDIT FY 2021 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$260M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$26M-71.8% YoY

Gross Profit

$20M80.2% margin

Operating Income

-$193M-756.1% margin

Net Income

-$193M-753.6% margin

EPS (Diluted)

$-2.85

Cash Flow

Operating Cash Flow

-$164M

Free Cash Flow

-$172M

Stock-Based Comp.

$43M

Balance Sheet

Total Assets

$677M

Total Liabilities

$124M

Stockholders' Equity

$554M

Cash & Equivalents

$204M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$26M	$91M	-71.8%
Gross Profit	$20M	-$67M	+130.5%
Operating Income	-$193M	-$135M	-43.2%
Net Income	-$193M	-$116M	-66.0%